United States · FDA National Drug Code directory

Carbidopa and Levodopa

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71205-879_a704c66b-9765-4219-868d-36e04628fe23
Product NDC
71205-879
Form
TABLET
Composition / generic term
Carbidopa and Levodopa
Labeler
Proficient Rx LP
Marketing category
ANDA
Marketing start / end (source format)
20210930
Source listing expiry
20261231

Source-listed ingredients

  • CARBIDOPA — 25 mg/1
  • LEVODOPA — 250 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET in 1 BOTTLE, PLASTIC (71205-879-00) · 71205-879-00
  • 1000 TABLET in 1 BOTTLE, PLASTIC (71205-879-11) · 71205-879-11
  • 30 TABLET in 1 BOTTLE, PLASTIC (71205-879-30) · 71205-879-30
  • 500 TABLET in 1 BOTTLE, PLASTIC (71205-879-55) · 71205-879-55
  • 60 TABLET in 1 BOTTLE, PLASTIC (71205-879-60) · 71205-879-60
  • 240 TABLET in 1 BOTTLE, PLASTIC (71205-879-64) · 71205-879-64
  • 120 TABLET in 1 BOTTLE, PLASTIC (71205-879-72) · 71205-879-72
  • 180 TABLET in 1 BOTTLE, PLASTIC (71205-879-78) · 71205-879-78
  • 90 TABLET in 1 BOTTLE, PLASTIC (71205-879-90) · 71205-879-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Carbidopa and Levodopa — United States | Molindra Medicines